Maravai LifeSciences(MRVI) - 2024 Q4 - Earnings Call Presentation

NASDAQ: MRVI Q4 and Year-end 2024 Financial Results 01 Welcome Deb Hart, Head of Investor Relations 02 10-K Update, Financial Results & Guidance Kevin Herde, Chief Financial Officer 03 Business Highlights & Strategy Trey Martin, Chief Executive Officer 04 Q&A Session Trey Martin, Chief Executive Officer Kevin Herde, Chief Financial Officer © 2025 Maravai LifeSciences 2 Forward Looking Statements and Use of Non-GAAP Financial Measures This presentation contains, and our officers and representatives may, from ...